It is important to note that Retatrutide remains an investigational compound and is not yet approved by regulatory bodies like the FDA
And clinical trial data specifically supporting weight management
Keeping skin well moisturized during heating season helps maintain injection site health
Transforming Lives, One Step at a Time Keep reading Mons Pubis Fat Loss on GLP-1s: The Pubic Area Change Nobody Mentions One change that surprises people on GLP-1 medications rarely comes up in conversation: the mons pubis, the soft fat pad over the pubic bone, How to Adjust Weight Loss Goals on GLP-1 Medications Adjust weight goals on GLP-1 meds by tracking body composition and labs, optimizing protein, activity, sleep, and working with your provider on dosing
Injection site reactions seem to be more commonly reported by people taking tirzepatide vs
Retatrutide is not approved by Health Canada for any use